6535 Nemours Pkwy, Orlando, FL, 32827 · (407) 567-4000
Beds
135
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$467.1M
FY 2025
Net income
-$16.8M
Patient care margin 2.4%
Discharges
3,882
Occupancy 56.4%
Clinicians
6
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $467.1M | $455.6M | 2.4% | -$16.8M | 3,882 | - | 0.2% | 69.1% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | - | - | - | $1,219.56 |
| APC 5154 Level 4 Airway Endoscopy | - | - | - | $2,832.62 |
| APC 8011 Comprehensive Observation Services |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $411.9M | $425.6M | -3.3% | $20.6M | 3,600 | - | 0.3% | 71.3% |
| 2023 | $356.6M | $326.0M | 8.6% | $71.3M | 3,600 | - | 0.4% | 74.5% |
| 2022 | $268.7M | $296.0M | -10.2% | $2.6M | 3,426 | - | 0.4% | 72.6% |
| 2021 | $247.3M | $254.0M | -2.7% | $31.9M | 3,245 | - | 0.2% | 80.3% |
| 2020 | $171.1M | $228.0M | -33.2% | -$6.3M | 2,936 | - | 0.1% | 74.7% |
| - |
| - |
| - |
| $2,090.36 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| BioMarin Pharmaceutical Inc. BMRN | 68 | $327K |
| Masimo Corporation MASI | 2 | $200K |
| Abbvie Inc. ABBV | 46 | $172K |
| Ultragenyx Pharmaceutical Inc. RARE | 59 | $154K |
| Hoffmann-La Roche Limited ROG.SW | 41 | $118K |
| AstraZeneca UK Limited AZN | 1 | $101K |
| Immedica Pharma US, Inc. | 16 | $85K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $53K |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $51K |
| Aurinia Pharma U.S., Inc. AUPH | 16 | $51K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Nemours Childrens Hospital, Florida is a nonprofit children's hospital in Orlando, FL with 135 beds, part of Nemours Childrens Health.
Nemours Childrens Hospital, Florida in Orlando, FL has 135 beds (fiscal year 2025 cost report). It discharged 3,882 inpatients that year, with 56.4% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Nemours Childrens Hospital, Florida reported net patient revenue of $467.1M and operating expenses of $455.6M, a margin on patient care of 2.4%. After other income and expenses its net income was -$16.8M (-3.8% of revenue), so it lost money that year.
Nemours Childrens Hospital, Florida is part of Nemours Childrens Health, a health system with 2 hospitals based in Jacksonville, FL. It is a nonprofit hospital.
Nemours Childrens Hospital, Florida has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, Nemours Childrens Hospital, Florida provides emergency services.
6 Medicare clinicians list Nemours Childrens Hospital, Florida as a hospital they work at, most often in Diagnostic Radiology, Nephrology, Cardiovascular Disease (Cardiology).
In 2025, companies reported $1.6M in payments to Nemours Childrens Hospital, Florida as a teaching hospital ($284K general and $1.4M for research) from 39 companies.